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cGMP- and cAMP-dependent protein kinases (cGK and
cAK) mediate the inhibitory effects of endothelium-
derived messenger molecules nitric oxide and prostacyclin
on platelets. To understand the mechanisms involved in
platelet inhibition we searched for new substrates of cGK
and cAK. We identified Rap1GAP2, the only GTPase-acti-
vating protein of Rap1 in platelets. Rap1 is a guanine-
nucleotide binding protein that controls integrin activity,
platelet adhesion and aggregation. Rap1GAP2 is required
to turn over Rap1-GTP to Rap1-GDP resulting in the inac-
tivation of integrins and reduced cellular adhesion. Using
phospho-specific antibodies we demonstrate phosphor-
ylation of endogenous Rap1GAP2 on serine 7 by cGK and
cAK in intact platelets. Yeast-two-hybrid screening
revealed an interaction of the phosphoserine/-threonine
binding adapter protein 14-3-3 with Rap1GAP2, and we
mapped the 14-3-3 binding site to the N-terminus of
Rap1GAP2 close to the cGK/cAK phosphorylation site. We
could show that 14-3-3 binding to Rap1GAP2 requires
phosphorylation of serine 9. Platelet activation by ADP
and thrombin treatment induces Rap1GAP2 serine 9
phosphorylation and enhances the attachment of 14-3-3
to Rap1GAP2. In contrast, phosphorylation of serine 7 by
cGK/cAK leads to the detachment of 14-3-3. Furthermore,
Rap1GAP2 serine 7 phosphorylation correlates with the
inhibition of Rap1-GTP formation by cGMP and cAMP in
platelets. Cell adhesion experiments provide additional
evidence that Rap1GAP2 is activated by the detachment of
14-3-3. Point mutants of Rap1GAP2 deficient in 14-3-3
binding inhibit Rap1-mediated cell adhesion significantly
stronger than a Rap1GAP2 mutant that binds 14-3-3 con-
stitutively. Our findings define a novel regulatory mecha-
nism that might contribute to both platelet activation and
endothelial inhibition of platelet adhesion and aggrega-
tion.
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